Iterum Therapeutics plc (ITRM) Financials

ITRM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 39.7 million 36.3 million
2023-06-30 51.0 million 43.9 million
2023-03-31 58.1 million 39.2 million
2022-12-31 66.8 million 38.8 million

ITRM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.3 million 142000
2023-06-30 -7.6 million 110000
2023-03-31 -9.6 million 393000
2022-12-31 -4.3 million 457000

ITRM Net Income

No data available :(

ITRM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 35.9 million - -
2023-06-30 44.7 million - -
2023-03-31 51.8 million - -
2022-12-31 60.8 million - -

ITRM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 13.0 million
2023-06-30 12.9 million
2023-03-31 12.7 million
2022-12-31 12.3 million

ITRM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3000 14.9 million 1.8 million -
2023-06-30 16114 9.0 million 1.9 million -
2023-03-31 16000 6.4 million 2.1 million -
2022-12-31 45000 5.8 million 2.1 million -

ITRM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 436000
2023-06-30 - 438000
2023-03-31 - 436000
2022-12-31 - 439000

ITRM

Price: $1.55

52 week price:
0.62
2.50

Earnings Per Share: -2.96 USD

P/E Ratio: -0.65

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 35952

Market Capitalization: 26.0 million

Links: